Angiography Imaging Systems Market Synopsis

The Angiography Imaging Systems is expected to grow at a significant growth rate, and the forecast period is 2022-2028, considering the base year as 2021.

Angiography also called arteriography is an imaging technique applied in medicine to help professionals in visualizing the anatomical details or lumen of blood vessels and organs of the body, like the arteries, veins, and heart chambers. Mainly performed on blood vessels and heart the procedure is also helpful in visualizing the flow of blood to and from the brain, which is helpful in diagnosing aneurysms and performing intervention work on coil-embolized aneurysms.

• Angiography Imaging Systems today, perform various angiography procedures and techniques which highly depend on the type necessary for the procedure as recommended by the healthcare expert. In angiography, a contrast agent will be introduced to the patient's blood, this agent shows up opaque in the angiograph film because it can absorb x-rays. this is usually followed by either an X-ray or fluoroscopy further, this contrast agent will make the network of veins and arteries visible for analysis. For blood vessels, angiography images are taken two to three frames per second to properly evaluate the flow of blood but for heart images, fifteen to thirty frames per second are taken by the expert performing the procedure.
• The images obtained from the angiography imaging procedure are analyzed by a cardiologist or an interventional radiologist to identify structure, narrowing, or any kind of blockage in the blood vessels. Angiography Imaging Systems are highly used in investigating problems like atherosclerosis, peripheral arterial disease, angina, blood clots, pulmonary embolism, and brain aneurysm.
• Moreover, the rising number of cases of such diseases is leading to more demand for Angiography Imaging Systems. Also, added benefits from these procedures like increased patient safety, faster recovery, and effectiveness are helping the growth of the market by increasing product application.

The Angiography Imaging Systems Market Trend Analysis

Rising Prevalence of Cardiovascular, Neurological and Oncological Diseases

• Growing Cases of Cardiovascular and other brain and tumor-related diseases where angiography imaging is necessary for diagnosing and addressing the disorders are the primary drivers for the growth of the angiography imaging systems market globally. In the past few years, cardiovascular disease has become a crucial disease affecting human health. Cardiovascular diseases are the ones causing the greatest number of deaths. According to WHO, around 17.9 million people died from CVDs in 2019, which is 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Also, the “World Health Report” has found that each year as many as 17.5 million people die due to cardiovascular diseases in the world.
• Today, Coronary heart disease is one of the most common cardiovascular diseases, and the unhealthy lifestyle of people worldwide is also a leading cause of vascular disease. Due to these, the initial and early prevention and diagnosis of coronary heart disease have become so critical, wherein Angiography Imaging plays a very crucial role.

Ongoing Innovation and Advances, And Growing Adoption of Minimally Invasive Surgeries Using Interventional Angiography

• Angiography was first started as a diagnostic tool, but today with the help of technological transformation in the last decade, it has become a basis for interventional therapy also. Angiography Imaging Systems have many advantages now as, it offers real-time, dynamic imaging using a traditional imaging device - such as x-rays or computed tomography (CT), and it also offers therapeutic options at the time of initial diagnosis to help doctors. Due to such innovative features and advancements, the market currently is experiencing and in the future is expected to experience greater growth.
• Additionally, the growing adoption of non-invasive interventions is offering greater opportunities for angiography imaging systems with greater sales through advancement. Conventional angiography is an invasive procedure, in diagnosing most intravascular pathologies and providing additional therapeutic options, invasive angiography is still highly applicable. However, Advances that are taking place in imaging technology in the last three decades have expanded the scope of angiography helping to include non-invasive techniques with the help of CT and magnetic resonance imaging technologies, which makes it a preferred option.
• Angiography with its evolution is now safe and painless procedure. There are several different types of angiography available today depending on the area of the body some common types include coronary angiography, cerebral angiography, pulmonary angiography, and renal angiography among others. Owning to its safety, sped, and cost-effectiveness Angiography Imaging Systems are expected to gain huge demand in the upcoming period.

Segmentation Analysis Of The Angiography Imaging Systems Market

Angiography Imaging Systems market segments cover the Type, Application, and End-User. By Type, the X-Ray angiography segment is Anticipated to Dominate the Market Over the Forecast period.

• In spite of the introduction of several alternative angiographic imaging techniques like magnetic resonance imaging, computed tomography, and ultrasound angiography in the angiography imaging systems like, X-Ray angiography remains the most dominant imaging modality, generating a revenue of more than $4 billion in a year in the United States alone.
• X-Ray angiography imaging system, includes a gantry and table system, x-ray generator, x-ray tube, image-recording devices, image intensifier, display monitors, and digital acquisition and processing systems. X-Ray angiography had evolved till this stage when it has become a routine part of diagnostic angiograms in most radiology departments. Due to such great use, the X-Ray angiography type holds a substantial share of the market.
• However, Technical advances in CT and MRI in cardiovascular along with encouraging clinical trials showing improved outcomes are also now resulting in the greater use of cardiovascular MRI and CT angiography in a wide range of cardiovascular diseases. The features offered like fast acquisition times and non-invasiveness with a three-dimensional display of data sets are leading to increasing in the demand for such types of angiography modalities. These features of MR and CT Angiography achieve similar images to conventional angiographic images with which radiologists and clinicians are familiar, making them a preferred choice and eventually boosting the growth in their adoption.  

Regional Analysis of The Angiography Imaging Systems Market

North America is Estimated to Dominate the Market Over the Forecast period.

• The North American Market of Angiography Imaging Systems is estimated to register considerable growth during the forecast period. The growth of the market in the region can be attributed to the growing prevalence of cardiovascular diseases, the changing lifestyle of the population residing in the developed countries of North America like the United States are mostly leading to people adopting unhealthy habits that are resulting in increased diseases and health concerns like obesity, heart problems, brain strokes any others. For Instance, a report by the Centers for Disease Control and Prevention shows that about 650,000 people in the United States die from heart disease every year. Also, it was figured that more than 795,000 people in the United States have a stroke every year, of which 610,000 are first or new strokes.
• Moreover, the North American region has a large number of Angiographic imaging system vendors that are continuously venturing to develop new technologies to address the growing number of cardiovascular disease investigations and emerging lab trends. The vendors in the region are the first to incorporate new innovative technologies to improve imaging systems in the world which makes the region set the product trend which is anticipated to hike the growth of the market over the forecast period. In Addition to all these, the growing geriatric population, and growing cardiovascular diseases through obesity and bad eating habits are expected to boost the demand for angiography imaging systems to diagnose kidney and heart-related problems occurring across the region.

Covid-19 Impact Analysis On Angiography Imaging Systems Market

• COVID-19 has had a slightly disapproving effect during its initial phase in 2020, the market demand was considerably low during that period due to the classification of other medical problems than COVID-19 infection as unimportant. Many, clinical hospitals and surgical centers were unable to operate other medical issues due to their conversion into COVID care centers which impacted the growth of the Global Angiography Imaging Market considerably. Further, several countries or regions with inefficient healthcare systems felt the need for safe and effective solutions and alternatives to traditional clinical medicine which also includes challenges faced by the ophthalmology specialty which relies heavily on diagnostic imaging.
• However, the infection caused by the SARS-CoV-2 declared a global pandemic by WHO in March 2020, is mainly responsible for a potentially fatal syndrome called COVID-19, which is mainly a respiratory disease, but it also has some cardiac complications with a worsening prognosis. In this situation, Imaging Systems and technologies played an essential role in the diagnosis of all manifestations of the disease, as well as its related complications which led to a rise in the use of angiography imaging.  Moreover, even with the application of angiography in Cardiovascular diseases (CVDs) that are the leading cause of death worldwide during the pandemic period, it was also recommended worldwide to use imaging (computed tomography (CT) or chest radiography in patients with moderate to severe symptoms of COVID-19 which helped the Angiography Imaging Systems Vendors with an opportunity to boost their sales.

Top Key Players Covered in The Angiography Imaging Systems Market

• Canon Medical Systems (Japan)
• GE Healthcare (US)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers (Germany)
• Boston Scientific Corporation (US)
• Cordis Corporation (US)
• Angiodynamics (US)
• Omega Medical Imaging LLC (US)
• Shimadzu Corporation (Japan)
• Medtronic (Ireland)
• Braun Melsungen (Germany)
• Abbott Laboratories (US)
• Terumo (Japan) and Other Major Players

Key Industry Developments in the Angiography Imaging Systems Market

In November 2022, Canon Medical Systems USA, a subsidiary of Canon Medical Systems Corporation and a global leader in innovative diagnostic imaging technology, announced the launch of SP Configurations, Orian SP, and Galan SP. This new launch is oncoming with its AI-driven workflow solutions, equipped intelligent Ceiling Camera, and the Tablet UX mobile interface which is to deliver daily high-end performance. Further, 45 mT/m maximum gradient peaks and 200 mT/m/ms slew rates, the Fast 3D acceleration package, and ForeSee View automation are some additional features offered by the system.

In June 2022, Shimadzu Medical Systems, a leading manufacturer of advanced imaging systems announced the release of its New Angiography System Trinias at the SIR 2022. The new Trinias system uses AI deep learning technology that will help in improving the visibility of medical devices while using 40% or more lower*2 X-ray doses than previous models which makes it safer. This launch represents the first-time application of AI into the image processing engine of an angiography system.

In March 2022, Canon Medical Systems Corporation announced an agreement to acquire Nordisk Røntgen Teknik A/S, a 45-year-old Danish company, headquartered in Aarhus, with advanced technology for the development and manufacture of diagnostic X-ray and general radiography systems. With the agreement, Canon Medical will have access to European-based technology, development, and manufacturing for advanced multipurpose and motorized digital radiographic imaging solutions.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
 3.3 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Angiography Imaging Systems Market by Type
 5.1 Angiography Imaging Systems Market Overview Snapshot and Growth Engine
 5.2 Angiography Imaging Systems Market Overview
 5.3 X-Ray angiography
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 X-Ray angiography: Geographic Segmentation
 5.4 MRI angiography
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 MRI angiography: Geographic Segmentation
 5.5 CT angiography
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 CT angiography: Geographic Segmentation
 5.6 MR-CT angiography
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 MR-CT angiography: Geographic Segmentation

Chapter 6: Angiography Imaging Systems Market by Application
 6.1 Angiography Imaging Systems Market Overview Snapshot and Growth Engine
 6.2 Angiography Imaging Systems Market Overview
 6.3 Cardiology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Cardiology: Geographic Segmentation
 6.4 Neurology
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Neurology: Geographic Segmentation
 6.5 Oncology
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Oncology: Geographic Segmentation
 6.6 Vascular
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Vascular: Geographic Segmentation
 6.7 Peripheral Intervention
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Peripheral Intervention: Geographic Segmentation

Chapter 7: Angiography Imaging Systems Market by End-User
 7.1 Angiography Imaging Systems Market Overview Snapshot and Growth Engine
 7.2 Angiography Imaging Systems Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation
 7.4 Diagnostic & Imaging Centers
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Diagnostic & Imaging Centers: Geographic Segmentation
 7.5 Ambulatory Surgical Centers (ACCs)
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Ambulatory Surgical Centers (ACCs): Geographic Segmentation
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Geographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Angiography Imaging Systems Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Angiography Imaging Systems Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Angiography Imaging Systems Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 CANON MEDICAL SYSTEMS (JAPAN)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 GE HEALTHCARE (US)
 8.4 KONINKLIJKE PHILIPS N.V. (NETHERLANDS)
 8.5 SIEMENS HEALTHINEERS (GERMANY)
 8.6 BOSTON SCIENTIFIC CORPORATION (US)
 8.7 CORDIS CORPORATION (US)
 8.8 ANGIODYNAMICS (US)
 8.9 OMEGA MEDICAL IMAGING LLC (US)
 8.10 SHIMADZU CORPORATION (JAPAN)
 8.11 MEDTRONIC (IRELAND)
 8.12 BRAUN MELSUNGEN (GERMANY)
 8.13 ABBOTT LABORATORIES (US)
 8.14 TERUMO (JAPAN)
 8.15 OTHER MAJOR PLAYERS

Chapter 9: Global Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 X-Ray angiography
  9.2.2 MRI angiography
  9.2.3 CT angiography
  9.2.4 MR-CT angiography
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Cardiology
  9.3.2 Neurology
  9.3.3 Oncology
  9.3.4 Vascular
  9.3.5 Peripheral Intervention
 9.4 Historic and Forecasted Market Size By End-User
  9.4.1 Hospitals
  9.4.2 Diagnostic & Imaging Centers
  9.4.3 Ambulatory Surgical Centers (ACCs)
  9.4.4 Others

Chapter 10: North America Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 X-Ray angiography
  10.4.2 MRI angiography
  10.4.3 CT angiography
  10.4.4 MR-CT angiography
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Cardiology
  10.5.2 Neurology
  10.5.3 Oncology
  10.5.4 Vascular
  10.5.5 Peripheral Intervention
 10.6 Historic and Forecasted Market Size By End-User
  10.6.1 Hospitals
  10.6.2 Diagnostic & Imaging Centers
  10.6.3 Ambulatory Surgical Centers (ACCs)
  10.6.4 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 X-Ray angiography
  11.4.2 MRI angiography
  11.4.3 CT angiography
  11.4.4 MR-CT angiography
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Cardiology
  11.5.2 Neurology
  11.5.3 Oncology
  11.5.4 Vascular
  11.5.5 Peripheral Intervention
 11.6 Historic and Forecasted Market Size By End-User
  11.6.1 Hospitals
  11.6.2 Diagnostic & Imaging Centers
  11.6.3 Ambulatory Surgical Centers (ACCs)
  11.6.4 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 X-Ray angiography
  12.4.2 MRI angiography
  12.4.3 CT angiography
  12.4.4 MR-CT angiography
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Cardiology
  12.5.2 Neurology
  12.5.3 Oncology
  12.5.4 Vascular
  12.5.5 Peripheral Intervention
 12.6 Historic and Forecasted Market Size By End-User
  12.6.1 Hospitals
  12.6.2 Diagnostic & Imaging Centers
  12.6.3 Ambulatory Surgical Centers (ACCs)
  12.6.4 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 X-Ray angiography
  13.4.2 MRI angiography
  13.4.3 CT angiography
  13.4.4 MR-CT angiography
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Cardiology
  13.5.2 Neurology
  13.5.3 Oncology
  13.5.4 Vascular
  13.5.5 Peripheral Intervention
 13.6 Historic and Forecasted Market Size By End-User
  13.6.1 Hospitals
  13.6.2 Diagnostic & Imaging Centers
  13.6.3 Ambulatory Surgical Centers (ACCs)
  13.6.4 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Angiography Imaging Systems Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 X-Ray angiography
  14.4.2 MRI angiography
  14.4.3 CT angiography
  14.4.4 MR-CT angiography
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Cardiology
  14.5.2 Neurology
  14.5.3 Oncology
  14.5.4 Vascular
  14.5.5 Peripheral Intervention
 14.6 Historic and Forecasted Market Size By End-User
  14.6.1 Hospitals
  14.6.2 Diagnostic & Imaging Centers
  14.6.3 Ambulatory Surgical Centers (ACCs)
  14.6.4 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ANGIOGRAPHY IMAGING SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ANGIOGRAPHY IMAGING SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ANGIOGRAPHY IMAGING SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. ANGIOGRAPHY IMAGING SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ANGIOGRAPHY IMAGING SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY TYPE
TABLE 008. X-RAY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 009. MRI ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 010. CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 011. MR-CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 012. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY APPLICATION
TABLE 013. CARDIOLOGY MARKET OVERVIEW (2016-2028)
TABLE 014. NEUROLOGY MARKET OVERVIEW (2016-2028)
TABLE 015. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 016. VASCULAR MARKET OVERVIEW (2016-2028)
TABLE 017. PERIPHERAL INTERVENTION MARKET OVERVIEW (2016-2028)
TABLE 018. ANGIOGRAPHY IMAGING SYSTEMS MARKET BY END-USER
TABLE 019. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 020. DIAGNOSTIC & IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 021. AMBULATORY SURGICAL CENTERS (ACCS) MARKET OVERVIEW (2016-2028)
TABLE 022. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 023. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 024. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 026. N ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 028. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 030. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 031. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 032. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 033. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 034. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 038. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 039. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 040. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 041. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 042. ANGIOGRAPHY IMAGING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 043. CANON MEDICAL SYSTEMS (JAPAN): SNAPSHOT
TABLE 044. CANON MEDICAL SYSTEMS (JAPAN): BUSINESS PERFORMANCE
TABLE 045. CANON MEDICAL SYSTEMS (JAPAN): PRODUCT PORTFOLIO
TABLE 046. CANON MEDICAL SYSTEMS (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. GE HEALTHCARE (US): SNAPSHOT
TABLE 047. GE HEALTHCARE (US): BUSINESS PERFORMANCE
TABLE 048. GE HEALTHCARE (US): PRODUCT PORTFOLIO
TABLE 049. GE HEALTHCARE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): SNAPSHOT
TABLE 050. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 051. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 052. KONINKLIJKE PHILIPS N.V. (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. SIEMENS HEALTHINEERS (GERMANY): SNAPSHOT
TABLE 053. SIEMENS HEALTHINEERS (GERMANY): BUSINESS PERFORMANCE
TABLE 054. SIEMENS HEALTHINEERS (GERMANY): PRODUCT PORTFOLIO
TABLE 055. SIEMENS HEALTHINEERS (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. BOSTON SCIENTIFIC CORPORATION (US): SNAPSHOT
TABLE 056. BOSTON SCIENTIFIC CORPORATION (US): BUSINESS PERFORMANCE
TABLE 057. BOSTON SCIENTIFIC CORPORATION (US): PRODUCT PORTFOLIO
TABLE 058. BOSTON SCIENTIFIC CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. CORDIS CORPORATION (US): SNAPSHOT
TABLE 059. CORDIS CORPORATION (US): BUSINESS PERFORMANCE
TABLE 060. CORDIS CORPORATION (US): PRODUCT PORTFOLIO
TABLE 061. CORDIS CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. ANGIODYNAMICS (US): SNAPSHOT
TABLE 062. ANGIODYNAMICS (US): BUSINESS PERFORMANCE
TABLE 063. ANGIODYNAMICS (US): PRODUCT PORTFOLIO
TABLE 064. ANGIODYNAMICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. OMEGA MEDICAL IMAGING LLC (US): SNAPSHOT
TABLE 065. OMEGA MEDICAL IMAGING LLC (US): BUSINESS PERFORMANCE
TABLE 066. OMEGA MEDICAL IMAGING LLC (US): PRODUCT PORTFOLIO
TABLE 067. OMEGA MEDICAL IMAGING LLC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. SHIMADZU CORPORATION (JAPAN): SNAPSHOT
TABLE 068. SHIMADZU CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 069. SHIMADZU CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 070. SHIMADZU CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. MEDTRONIC (IRELAND): SNAPSHOT
TABLE 071. MEDTRONIC (IRELAND): BUSINESS PERFORMANCE
TABLE 072. MEDTRONIC (IRELAND): PRODUCT PORTFOLIO
TABLE 073. MEDTRONIC (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. BRAUN MELSUNGEN (GERMANY): SNAPSHOT
TABLE 074. BRAUN MELSUNGEN (GERMANY): BUSINESS PERFORMANCE
TABLE 075. BRAUN MELSUNGEN (GERMANY): PRODUCT PORTFOLIO
TABLE 076. BRAUN MELSUNGEN (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ABBOTT LABORATORIES (US): SNAPSHOT
TABLE 077. ABBOTT LABORATORIES (US): BUSINESS PERFORMANCE
TABLE 078. ABBOTT LABORATORIES (US): PRODUCT PORTFOLIO
TABLE 079. ABBOTT LABORATORIES (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. TERUMO (JAPAN): SNAPSHOT
TABLE 080. TERUMO (JAPAN): BUSINESS PERFORMANCE
TABLE 081. TERUMO (JAPAN): PRODUCT PORTFOLIO
TABLE 082. TERUMO (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 083. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 084. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 085. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY TYPE
FIGURE 012. X-RAY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 013. MRI ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 014. CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 015. MR-CT ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 016. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 017. CARDIOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 018. NEUROLOGY MARKET OVERVIEW (2016-2028)
FIGURE 019. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 020. VASCULAR MARKET OVERVIEW (2016-2028)
FIGURE 021. PERIPHERAL INTERVENTION MARKET OVERVIEW (2016-2028)
FIGURE 022. ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY END-USER
FIGURE 023. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 024. DIAGNOSTIC & IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 025. AMBULATORY SURGICAL CENTERS (ACCS) MARKET OVERVIEW (2016-2028)
FIGURE 026. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 027. NORTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. EUROPE ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. ASIA PACIFIC ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. MIDDLE EAST & AFRICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. SOUTH AMERICA ANGIOGRAPHY IMAGING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)